Management
Ronald L. Stotish - Executive Director, President and Chief Executive Officer
David A. Frank - Chief Financial Officer
Henry Clifford - Vice-President of Sales & Marketing
John Buchanan - Director of Research and Development
Ronald L. Stotish - Executive Director, President and Chief Executive Officer
David A. Frank - Chief Financial Officer
Henry Clifford - Vice-President of Sales & Marketing
John Buchanan - Director of Research and Development
| Ronald L. Stotish - Executive Director, President and Chief Executive Officer Ronald L. Stotish, Ph.D. was appointed an Executive Director, President and CEO of Aqua Bounty Technologies in May 2008. Dr. Stotish joined Aqua Bounty Technologies in 2006 as Vice President for Regulatory Affairs, and most recently was Senior Vice President for R&D and Regulatory Affairs. Prior to joining Aqua Bounty, Dr. Stotish was Executive Vice President for R&D at MetaMorphix, Inc. He has served as Vice President for Pharmaceutical Research and Development at Fort Dodge Animal Health, and held a variety of positions at American Cyanamid. He began his career in research at Merck. Dr. Stotish has degrees in biochemistry and over thirty eight years experience in the discovery, development, and commercialization of new animal health products. |
 |
| David A. Frank - Chief Financial Officer David Frank was appointed CFO in October 2007. Previously he served as President and General Manager of TekCel LLC, a subsidiary of Magellan Biosciences, after serving as Magellan's CFO since the company's founding in 2004 and as TekCel's CFO since 2003. Mr. Frank has over 25 years of financial-management experience, including as CFO of SmartEnergy during its period of rapid growth from less than $1 million in revenue in 2000 to more than $45 million in 2002. He served as the corporate controller for Moldflow when the company completed its successful public offering and his earlier experience includes financial roles at PerSeptive Biosystems, Lotus Development Corporation, Apollo Computer, and Honeywell. He has a BS in finance and accounting from Boston College and an MBA from Babson College. Mr. Frank is the Company Secretary. |
 |
| Henry Clifford - Vice-President of Marketing & Sales Henry Clifford was appointed Vice-President of Marketing & Sales in June 2005 and is responsible for the commercial deployment of the company’s product lines. Mr. Clifford is an internationally recognized authority on shrimp farming and genetic improvement programs with a career spanning more than 30 years in the industry. He developed and provided technical direction for some of the largest shrimp aquaculture ventures in the Americas, and has provided technical services in aquaculture to more than 250 clients in 20 countries. |
 |
| John Buchanan - Director of Research and Development Dr. John Buchanan is the Director of Research and Development for Aqua Bounty. He has held research positions at Louisiana State University, the University of California at San Diego School of Medicine, and was most recently the Director of Aquaculture Therapeutics at Kent SeaTech Corporation, a leader in the application of science to farmed fish. After his undergraduate degree from Texas A&M University he worked on methods for transgenic manipulation of eastern oysters for his doctoral research in Oceanography and Coastal Sciences at LSU. Dr. Buchanan’s finfish expertise includes work with zebrafish, white and striped bass, channel catfish, red and black drum, and speckled trout, and includes research on transgenic manipulation, artificial spawning, milt cryopreservation, ploidy manipulation, and production of all female populations. Dr. Buchanan has done extensive research into the genetic basis for virulence in aquatic and human pathogens and has worked in vaccine development and development of novel therapeutics for aquaculture. He has been with Aqua Bounty since April, 2007. Back to top |
 |
